Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Net Margin (2016 - 2025)

Historic Net Margin for Fortress Biotech (FBIO) over the last 12 years, with Q3 2025 value amounting to 20.84%.

  • Fortress Biotech's Net Margin rose 1236500.0% to 20.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.57%, marking a year-over-year increase of 834700.0%. This contributed to the annual value of 96.91% for FY2024, which is 156500.0% down from last year.
  • Fortress Biotech's Net Margin amounted to 20.84% in Q3 2025, which was up 1236500.0% from 81.37% recorded in Q2 2025.
  • Fortress Biotech's Net Margin's 5-year high stood at 81.37% during Q2 2025, with a 5-year trough of 341.2% in Q4 2021.
  • Over the past 5 years, Fortress Biotech's median Net Margin value was 137.06% (recorded in 2024), while the average stood at 133.39%.
  • Per our database at Business Quant, Fortress Biotech's Net Margin tumbled by -1665400bps in 2021 and then skyrocketed by 1709200bps in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's Net Margin stood at 341.2% in 2021, then skyrocketed by 48bps to 176.22% in 2022, then skyrocketed by 68bps to 56.59% in 2023, then fell by -13bps to 63.84% in 2024, then skyrocketed by 133bps to 20.84% in 2025.
  • Its last three reported values are 20.84% in Q3 2025, 81.37% for Q2 2025, and 96.77% during Q1 2025.